Apellis Pharmaceuticals Aktie
15,97
EUR
-0,68
EUR
-4,08
%
18,23
USD
+0,05
USD
+0,28
%
Werbung
Apellis Pharmaceuticals Aktie Analyse
01.08.19 | Apellis Pharmaceuticals Overweight | Cantor Fitzgerald | |
30.07.18 | Apellis Pharmaceuticals Buy | B. Riley FBR | |
24.05.18 | Apellis Pharmaceuticals Overweight | Cantor Fitzgerald | |
08.02.18 | Apellis Pharmaceuticals Buy | B. Riley FBR, Inc. |
Werbung
Werbung